PM.20.054 – Targeting auto-immune driven microvascular disease and fibrosis in Systemic Sclerosis
Route: Personalised medicine: the individual at the centre
cluster question: 098 How can we use breakthroughs in basic biomedical research to develop new medicines?
Microvascular disease is an important feature of many autoimmune diseases and one of the earliest signs of pathology in patients […]
View the initiative
PM.20.042 – FibroTheranostics: Theranostics for the diagnosis and treatment of fibrosis-driven organ failure
Route: Personalised medicine: the individual at the centre
cluster question: 104 How do we develop minimally invasive techniques and interventions for diagnosis, prognosis, and treatment?
The mission of the FibroTheranostics is to diagnose and treat fibrosis-driven organ failure. Fibrosis affects millions of people worldwide, accounting […]
View the initiative
HCR.20.078 – Time to relax: breaking the vicious circle of autonomic dysregulation, fibrosis and right ventricular maladaptation in pulmonary arterial hypertension.
Route: Health care research, sickness prevention and treatment
cluster question: 089 How can we improve our understanding and treatment of pulmonary diseases?
Pulmonary arterial hypertension (PAH) is a fatal lung disease characterized by abnormal remodeling of the pulmonary vessels, leading to a […]
View the initiative